Harper Hubbeling
Impact in
- Immunology top 5%
- Immune cells in cancer
- Macrophage Migration Inhibitory Factor
- Immune Cell Function and Interaction
- Oncology top 5%
- Lung Cancer Research Studies
Papers in
- Oncology 19
- CAR-T cell therapy research 9
- Lung Cancer Research Studies 6
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 4
- Brain Metastases and Treatment 3
- Co-authors
- Richard N. Hanna (2 shared papers)Frédéric Geissmann (2 shared papers)Catherine C. Hedrick (2 shared papers)Jennifer A. Punt (2 shared papers)Dominika Nąckiewicz (1 shared paper)Leo Carlin (1 shared paper)Angela M. Green (1 shared paper)Justin F. Gainor (6 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (7 papers)JCO Precision Oncology (3 papers)Blood (3 papers)Blood Advances (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesUnited KingdomPoland
In The Last Decade
Harper Hubbeling
32 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 79
- Immunology 717
- Oncology 840
- Pulmonary and Respiratory Medicine 940
- Cancer Research 266
- Neurology 119
Countries citing papers authored by Harper Hubbeling
This map shows the geographic impact of Harper Hubbeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harper Hubbeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harper Hubbeling more than expected).
Fields of papers citing papers by Harper Hubbeling
This network shows the impact of papers produced by Harper Hubbeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harper Hubbeling. The network helps show where Harper Hubbeling may publish in the future.
Co-authors
The 25 scholars most cited alongside Harper Hubbeling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 523 | |
| 2 | 2011 | 372 | |
| 3 | 2018 | 248 | |
| 4 | 2017 | 233 | |
| 5 | 2019 | 134 | |
| 6 | 2018 | 119 | |
| 7 | 2018 | 111 | |
| 8 | 2021 | 106 | |
| 9 | 2018 | 103 | |
| 10 | 2017 | 77 | |
| 11 | 2014 | 73 | |
| 12 | 2018 | 56 | |
| 13 | 2022 | 41 | |
| 14 | 2014 | 29 | |
| 15 | 2024 | 21 | |
| 16 | 2024 | 21 | |
| 17 | 2024 | 14 | |
| 18 | 2025 | 9 | |
| 19 | 2022 | 8 | |
| 20 | 2021 | 6 |
About Harper Hubbeling
Harper Hubbeling is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Genetics and Dermatology, having authored 39 papers that have together received 2.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Integrated Circuits and Semiconductor Failure Analysis (3 papers), Brain Metastases and Treatment (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Immunology (717 citations), Oncology (840 citations), Pulmonary and Respiratory Medicine (940 citations), Cancer Research (266 citations) and Neurology (119 citations). Harper Hubbeling has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Richard N. Hanna, Frédéric Geissmann, Catherine C. Hedrick, Jennifer A. Punt, Dominika Nąckiewicz, Leo Carlin, Angela M. Green, Justin F. Gainor, Alice Tsang Shaw and Beow Yong Yeap. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, JCO Precision Oncology, Blood, Blood Advances and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.